Patient activation Not Applicable
Conditions
Interventions
There are two intervention arms and the intervention consists of two steps.
Step 1: Patients from both intervention groups will receive a postal letter encouraging them to talk to their GP about thei
Sponsors
University of Zurich
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients insured at SWICA 2. German-speaking 3. 60 years or older 4. Using at least five different drugs, at least three original packages over the last 12 months and at least one month distance in between. Exception of this 12 months rule and included in the data are androgens, vitamin B12, antineoplastic and immunemodulating agents and drugs for treating osteoporosis. Excluded drugs are topical (including dermatologicals, nasal-, throat-, cough and cold preparations, transdermal opioids), intravenous and homeopathic drugs, vaccines, surgical dressings, contrast agents as well as products from these pharmaceutical companies (Ceres®, Similisan®, Omnida®, Spagyros® and Vogel®) 5. Signed Informed Consent after being informed
Exclusion criteria
Exclusion criteria: Patients insured at SWICA with a GP guided healthcare plan
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Having a GP consultation with a medication review activity between the start of the study (when the patients of the intervention group receive the letter) and the moment of filling in the questionnaire, 4 months later. Information is asked for in the questionnaire collected at 4 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| From claims data: 1. Number of drugs using ATC coding 2. Number of physicians prescribing drugs 3. Number of healthcare contacts (Emergency Department, hospital, specialist, GP) 4. Hospitalisation 5. Cost of drugs and healthcare services Measurement takes place at the start of the study (when the letter has been sent to the patients of the intervention groups, T0), after 4 months (T1), after 7 months (T2), and after 10 months (T3). The study takes into account a delay of three months for the time it takes for patients to claim their used services and drugs and for the insurer to process this. From questionnaires (if not reachable: by telephone interviews) 1. Barriers towards having a GP consultation, if the patient has not had a consultation Only intervention groups: 1. Attitude towards receiving information from insurer to activate patients 2. Use of the algorithm during consultation with GP. If the algorithm is not used: what were barriers towards use of the algorithm 3. Readiness for alternative healthcare provider counseling, for example with pharmacist or physician santé24 or any other healthcare provider 4. Having a medication review with another physician 5. Having a medication review with telemedicine physician All outcomes will be collected per patient | — |
Countries
Switzerland
Outcome results
None listed